Table 2 Univariate regression analysis to identify risk factors affecting the treatment time of PLA. (The outcome of this study is the number of days of treatment received by the patients. A lower HR indicates a longer duration of treatment required for the patients).
Characteristic | HR | 95%CI | P value |
|---|---|---|---|
Gender | |||
Male | - | - | - |
Female | 0.963 | 0.681-1.361 | 0.830 |
Age (years) | 0.987 | 0.975-0.0998 | 0.026 |
Fever | |||
No | - | - | - |
Yes | 0.570 | 0.400-0.811 | <0.01 |
Abdominal pain | |||
No | - | - | - |
Yes | 0.868 | 0.601-1.253 | 0.450 |
Biliary stone history | |||
No | - | - | - |
Yes | 1.519 | 0.988-2.336 | 0.057 |
Hypertension | |||
No | - | - | - |
Yes | 1.172 | 0.833-1.645 | 0.362 |
Septic shock | |||
No | - | - | - |
Yes | 0.340 | 0.214-0.541 | <0.01 |
Pneumonia | |||
No | - | - | - |
Yes | 0.836 | 0.566-1.236 | 0.369 |
Percutaneous Biliary Drainage | |||
No | - | - | - |
Yes | 0.556 | 0.355-0.873 | 0.010 |
Surgical history | |||
No | - | - | - |
Yes | 0.734 | 0.441-1.224 | 0.236 |
Abscess location | |||
Right lobe | - | - | - |
Left lobe | 1.435 | 0.915-2.250 | 0.116 |
Multiple | 1.127 | 0.593-2.142 | 0.716 |
Size (cm) | 0.867 | 0.807-0.933 | <0.01 |
Bacteria | |||
Klebsiella pneumoniae | - | - | - |
Other | 1.542 | 1.020-2.331 | 0.040 |
WBC (×\(\:{10}^{9}\)/L) | 0.963 | 0.932-0.995 | 0.024 |
HB (g/L) | 0.996 | 0.982-1.010 | 0.566 |
PCT (ng/ml) | 0.998 | 0.992-1.004 | 0.503 |
CRP (mg/L) | 0.999 | 0.997-1.001 | 0.396 |
AST (U/L) | 0.995 | 0.993-0.998 | <0.01 |
ALT (U/L) | 0.998 | 0.994-1.001 | 0.134 |
D-D (mg/L) | 0.992 | 0.979-1.006 | 0.271 |
